Be confident in your go or no go decisions with translationally relevant data delivered by JAX preclinical oncology solutions. By combining genetically defined tumors with cutting-edge mouse models and unique human immune cell engraftment, JAX enables the validation of diverse oncology drug discovery candidates in an array of in vivo platforms that better recapitulate the human condition.
We are committed to providing you with the most innovative pre-clinical models to delineate the mechanisms underlying disease and enable you to select efficacious drugs to treat individualized targeted tumor types.
We offer customizable study designs, direct access to a comprehensive collection of patient-derived-xenograft (PDX) mouse models, cancer cell line xenografted models, and immuno-oncology platforms humanized with both PDX and human immune systems to test the effectiveness of novel or existing immunotherapeutic compounds.
Developing the most sophisticated models and applications, we are committed to providing you with the tools that propel effective treatments for cancer. Our mice and service solutions combine innovation, reliability,and commitment to customer service to offer you the most clinically-relevant mouse models and precision services. Through our industry-leading animal health and genetic stability programs, our team of study directors and mouse husbandry professionals ensures that mouse strains you receive are uniform, well-characterized, and have the highest health quality available.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.
